IP Library Granted Patent US 9,402,859
Granted Patent B1
US 9,402,859 · App. 14/172,376 · Granted Aug 2, 2016

Devices, compositions and methods for bone and tissue augmentation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,402,859
App. No.
14/172,376
Granted
Aug 2, 2016
Kind
B1
Abstract

Various polymeric materials and delivery systems are described, along with systems and methods for using them for bone and tissue augmentation, such as for the stabilization and/or correction of spinal compression fractures.

Claims (19)

1. A structural alloplastic bone graft composition for augmentation, repair and/or fusion of bone, comprising:

(i) a biodegradable side chain crystallizable polymer having a first order transition above the body temperature of a patient, the biodegradable side chain crystallizable polymer having a flowable property at a delivery temperature above the transition temperature, the delivery temperature sufficiently low to avoid damage to tissue adjacent a delivery site with the patient's body;

(ii) an osteoconductive material; and

(iii) an osteoinductive material,

wherein the side chain crystallizable polymer comprises an amount of polar groups selected to increase the adhesion of the side chain crystallizable polymer to a bone tissue.

2. The structural alloplastic bone graft composition of claim 1 , wherein the biodegradable side chain crystallizable polymer comprises a —(CH 2 )n- group in a side chain, where n is an integer in the range of about 6 to about 30.

3. The structural alloplastic bone graft composition of claim 2 , where n is an integer in the range of about 20 to about 30.

4. The structural alloplastic bone graft composition of claim 1 , wherein the biodegradable side chain crystallizable polymer is a copolymer comprising at least a first recurring unit having an optional —(CH 2 )m- group where m is an integer in the range of about 0 to about 5; and at least a second recurring unit having a —(CH 2 )n- group where n is an integer in the range of about 6 to about 30.

5. The structural alloplastic bone graft composition of claim 4 , wherein at least one of the recurring units is an alkyl methacrylate.

6. The structural alloplastic bone graft composition of claim 4 , wherein the copolymer comprises two or more recurring units selected from the group consisting of methyl methacrylate, ethyl methacrylate, hexyl methacrylate, and behenyl methacrylate.

7. The structural alloplastic bone graft composition of claim 1 , wherein

(i) the polymer has a solid state when within a first temperature range, the first temperature range selected to substantially correspond to temperatures generally found in anatomical bone structures of living mammals, the solid state having mechanical properties suitable for supporting and/or augmenting bone tissue;

(ii) the polymer has a second transition temperature range, the second transition temperature range being above the first temperature range;

(iii) the polymer has an extrudable fluid state when in a third temperature range, the third temperature range being above the second temperature range; the third temperature range selected to correspond to therapeutically acceptable temperatures for the bone tissue being treated, and

(iv) when the polymer is in the extrudable fluid state in the third temperature range, the composition has a viscosity sufficiently low to permit injection into the bone tissue being treated.

8. The structural alloplastic bone graft composition of claim 7 , wherein the first temperature range is from about 37° C. to about 41° C.

9. The structural alloplastic bone graft composition of claim 7 , wherein the third temperature range is from about 45° C. to about 100° C.

10. The structural alloplastic bone graft composition of claim 9 , wherein the third temperature range is from about 50° C. to about 80° C.

11. The structural alloplastic bone graft composition of claim 1 , further comprising a radio-opaque additive.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2020
From: REVA MEDICAL, INC.
To: REVA MEDICAL, LLC
Reel/Frame 054622/0316 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Feb 27, 2020
From: GOLDMAN SACHS INTERNATIONAL, AS ADMINISTRATIVE AGENT
To: REVA MEDICAL, INC.
Reel/Frame 052045/0383 →
NOTICE OF GRANT OF SECURITY INTEREST IN U.S. PATENTS Recorded Apr 9, 2019
From: REVA MEDICAL, INC.
To: GOLDMAN SACHS INTERNATIONAL AS ADMINISTRATIVE AGENT
Reel/Frame 048834/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2017
From: STEIN, MONI; BRANDOM, DON; KABALNOVA, LIOUBOV; HOWARD, STEVE; DENNIS, ROBERT F.
To: REVA MEDICAL INC.
Reel/Frame 040872/0300 →